Publisher: John Wiley & Sons Inc
E-ISSN: 1532-6535|22|6|843-852
ISSN: 0009-9236
Source: CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.22, Iss.6, 1977-12, pp. : 843-852
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Half‐life extended factor VIII for the treatment of hemophilia A
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. :
THE CONCEPT OF BIOLOGIC HALF‐LIFE IN RELATION TO SENESCENCE
JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 17, Iss. 10, 1969-10 ,pp. :
Transition considerations for extended half‐life factor products
HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. :